{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:24:48Z","timestamp":1790036688195,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.vaccine.2005.02.020","type":"journal-article","created":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T12:21:40Z","timestamp":1110889300000},"page":"3808-3813","source":"Crossref","is-referenced-by-count":47,"title":["Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge"],"prefix":"10.1016","volume":"23","author":[{"given":"K.","family":"Karaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Austgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Teehee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Siger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Grosenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Loosemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Audonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nordgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Minke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.02.020_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.20506\/rst.19.1.1201","article-title":"West Nile viral Encephalitis","volume":"19","author":"Komar","year":"2000","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.vaccine.2005.02.020_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3181\/00379727-82-20085","article-title":"Response of young dogs to West Nile virus","volume":"82","author":"Reagan","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2005.02.020_bib4","first-page":"145","article-title":"Studies on the occurrence and distribution of HI antibodies against arboviruses in the serum of domestic mammals in Puglia","volume":"7","author":"Bonaduce","year":"1977","journal-title":"Folia vet lat"},{"key":"10.1016\/j.vaccine.2005.02.020_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9975(89)90090-X","article-title":"Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial","volume":"100","author":"Blackburn","year":"1989","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3201\/eid0704.010424","article-title":"Exposure of domestic mammals to West Nile virus during outbreak of human Encephalitis, New York city, 1999","volume":"4","author":"Komar","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2005.02.020_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/104063870301500404","article-title":"Serological, reverse transcriptase-polymerase chain reaction, and immunohistochemical detection of West Nile virus in a clinically affected dog","volume":"15","author":"Buckweitz","year":"2003","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2005.02.020_bib8","unstructured":"Kile JC, Panella NA, Chow CC, Komar N, MacNeil A, Bunning ML. Post-epidemic West Nile virus serosurvey of dogs and cats-Louisiana, 2002, Proc 139 Ann Meet AVMA, Denver CO, USA, 2003."},{"key":"10.1016\/j.vaccine.2005.02.020_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3201\/eid0910.020617","article-title":"West Nile virus Encephalitis and myocarditis in wolf and dog","volume":"9","author":"Lichtensteiger","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2005.02.020_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3201\/eid1001.020616","article-title":"Experimental infection of cats and dogs with West Nile virus","volume":"10","author":"Austgen","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2005.02.020_bib12","first-page":"221","article-title":"Recombinant canarypox vaccine carrying PrM\/E genes of West Nile virus protects horses against a West Nile virus mosquito-challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib13","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Efficacy in horses of a single dose of an ALVAC recombinant West Nile Virus (WNV) vaccine, measured by protection to a natural challenge using WNV-infected mosquitoes","volume":"65","author":"Siger","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2005.02.020_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid0804.010239","article-title":"Experimental infection of horses with West Nile virus","volume":"8","author":"Bunning","year":"2002","journal-title":"Emerg Inf Dis"},{"key":"10.1016\/j.vaccine.2005.02.020_bib15","first-page":"65","article-title":"Safe and effective poxvirus vectors-NYVAC and ALVAC","volume":"82","author":"Paoletti","year":"1994","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2005.02.020_bib16","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a non-infectious recombinant antigen that can be used in enzyme-linked immunosorbant assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib17","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib18","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile Encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib19","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus Encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib20","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.171.5.2524","article-title":"IFN-\u03b3-producing \u03b3\u03b4T cells help control murine West Nile virus infection","volume":"171","author":"Wang","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib21","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.02.020_bib22","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese Encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05002975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05002975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T09:25:06Z","timestamp":1586165106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05002975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":20,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0264410X05002975"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.02.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}